PSB-603
| PSB-603 | |
|---|---|
| [[File:|frameless|220px|alt=Chemical structure of PSB-603|Chemical structure of PSB-603]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
PSB-603 is a selective antagonist of the adenosine A2B receptor, a subtype of the adenosine receptor family. It is primarily used in research settings to study the physiological and pathological roles of the A2B receptor, which is implicated in various processes such as inflammation, cancer, and cardiovascular diseases.
Pharmacology
PSB-603 exhibits high selectivity and affinity for the adenosine A2B receptor, distinguishing it from other adenosine receptor subtypes such as A1, A2A, and A3. This selectivity makes it a valuable tool for dissecting the specific functions of the A2B receptor in various biological systems.
Mechanism of Action
As an antagonist, PSB-603 binds to the A2B receptor and inhibits its activation by endogenous adenosine. This blockade can modulate downstream signaling pathways, which are often mediated by G protein-coupled receptors (GPCRs) and involve the regulation of cyclic adenosine monophosphate (cAMP) levels.
Therapeutic Potential
Research suggests that PSB-603 and other A2B receptor antagonists may have therapeutic potential in treating conditions such as asthma, chronic obstructive pulmonary disease (COPD), cancer, and diabetes. By inhibiting the A2B receptor, these compounds can reduce inflammation and tumor growth, as well as improve insulin sensitivity.
Research Applications
PSB-603 is widely used in preclinical studies to explore the role of the A2B receptor in various disease models. It helps in understanding the receptor's involvement in immune responses, tumor microenvironment modulation, and metabolic regulation.
Safety and Toxicology
As a research chemical, PSB-603 is not approved for human use. Its safety profile is primarily evaluated in laboratory settings, and it is handled with caution to prevent exposure.
Also see
| Pharmacomodulation | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
